Murai M, Maeda Y, Hagiwara D, Miyake H, Ikari N, Matsuo M, Fujii T
Department of Pharmacology, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan.
Eur J Pharmacol. 1993 May 12;236(1):7-13. doi: 10.1016/0014-2999(93)90220-c.
The effects of FK888, an NK1 receptor antagonist, on airway constriction and airway plasma extravasation induced by neurokinins and capsaicin were investigated in guinea pigs. FK888 inhibited substance P (10(-8) M)- and neurokinin A (10(-9) M)-induced contraction of isolated guinea pig trachea, with IC50 values of 3.2 x 10(-8) and 4.2 x 10(-6) M, respectively. FK888 given i.v. inhibited substance P (13.5 micrograms kg-1)-induced airway constriction with an ED50 value of 0.40 mg kg-1 but did not inhibit neurokinin A (1.1 micrograms kg-1)- and capsaicin (3.1 micrograms kg-1)-induced airway constriction at a dose of 1 mg kg-1. On the other hand, FK888 given i.v. inhibited airway plasma extravasation induced by substance P (1.3 micrograms kg-1), neurokinin A (11 micrograms kg-1) and capsaicin (100 micrograms kg-1) with equal potency and ED50 values of 0.011, 0.0063 and 0.019 mg kg-1, respectively. When FK888 was given locally (into the airway directly) inhibitory activities were more potent than following i.v. administration. In this case FK888 inhibited substance P-, neurokinin A- and capsaicin-induced airway constriction with ED50 values of 3.2, 190 and 550 micrograms kg-1, respectively, suggesting that an about 100 times higher dose is required to inhibit neurokinin A- and capsaicin-induced airway constriction than substance P-induced constriction. FK888 given orally was also effective in substance P-, neurokinin A- and capsaicin-induced airway plasma extravasation with ED50 values of 4.2, 5.9 and 9.5 mg kg-1.(ABSTRACT TRUNCATED AT 250 WORDS)
在豚鼠中研究了NK1受体拮抗剂FK888对神经激肽和辣椒素诱导的气道收缩及气道血浆外渗的影响。FK888抑制P物质(10⁻⁸ M)和神经激肽A(10⁻⁹ M)诱导的离体豚鼠气管收缩,IC50值分别为3.2×10⁻⁸和4.2×10⁻⁶ M。静脉注射FK888抑制P物质(13.5微克/千克)诱导的气道收缩,ED50值为0.40毫克/千克,但在1毫克/千克剂量时不抑制神经激肽A(1.1微克/千克)和辣椒素(3.1微克/千克)诱导的气道收缩。另一方面,静脉注射FK888以同等效力抑制P物质(1.3微克/千克)、神经激肽A(11微克/千克)和辣椒素(100微克/千克)诱导的气道血浆外渗,ED50值分别为0.011、0.0063和0.019毫克/千克。当FK888局部给药(直接注入气道)时,其抑制活性比静脉给药更强。在这种情况下,FK888抑制P物质、神经激肽A和辣椒素诱导的气道收缩,ED50值分别为3.2、190和550微克/千克,这表明抑制神经激肽A和辣椒素诱导的气道收缩所需剂量比抑制P物质诱导的收缩高约100倍。口服FK888对P物质、神经激肽A和辣椒素诱导的气道血浆外渗也有效,ED50值分别为4.2、5.9和9.5毫克/千克。(摘要截短至250字)